Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
January 7, 2026
Approximately 5 minutes
Labelling Requirements for Medical Devices Including In Vitro Diagnostic Devices – Health Canada Guidance
Labelling Requirements for Medical Devices Including In Vitro Diagnostic Devices – Health Canada Guidance
Purpose and Legal Basis
This guidance document provides detailed requirements for labelling medical devices, including in vitro diagnostic (IVD) devices, under sections 21 to 23 of the Medical Devices Regulations. Proper labelling ensures users have necessary information for safe and effective use, including identification, instructions, warnings, and contraindications. The guidance covers labels on the device itself, outer packaging, and accompanying materials (e.g., instructions for use, operator manuals). Guidance on Labelling of Medical Devices Including In Vitro Diagnostic Devices - Appendices - Canada.ca
Core Labelling Requirements
All medical devices must include:
- Device Name and Identifier: Name, model/catalogue number, or unique device identifier (UDI) if applicable.
- Manufacturer Information: Name and address of the manufacturer or authorized representative in Canada.
- Intended Use/Purpose: Clear statement of what the device is intended to do.
- Warnings and Precautions: Information on risks, contraindications, limitations, and safe handling.
- Storage and Handling Conditions: Temperature, humidity, light protection, or other requirements.
- Sterility Status: If applicable, indication of sterile condition and sterilization method.
- Expiry Date or Shelf Life: For devices with limited shelf life.
- Single-Use Statement: If the device is intended for single use only.
Special Requirements for IVD Devices
IVD labelling must additionally include:
- List of Reagents or Components: For kits, complete list of reagents, calibrators, controls.
- Performance Characteristics: Sensitivity, specificity, precision, or other relevant parameters.
- Sample Type and Volume: Acceptable specimen types and required volumes.
- Interpretation of Results: Clear instructions on how to read and interpret test results.
- Limitations of the Procedure: Known interferences, cross-reactivity, or limitations.
Language and Format Requirements
- Labels must be in English and French, or provide both languages in accompanying materials.
- Text must be legible, permanent, and prominently displayed.
- Symbols may be used if explained in accompanying materials (reference to ISO 15223-1 recommended).
Appendices and Practical Guidance
- Appendix A: Examples of minimum labelling requirements by device class and type.
- Appendix B: Specific labelling for custom-made devices and systems.
- Appendix C: Guidance on UDI implementation and barcoding.
- Appendix D: Special considerations for software-containing devices and combination products.
Practical Considerations
- Labelling must remain accurate throughout the device lifecycle; changes affecting safety or performance require notification or new licence.
- Distributors and importers must ensure labelling complies before market entry.
- Electronic labelling (e-label) may be acceptable for certain devices if users have reliable access.
- Maintain records of labelling versions for post-market surveillance.
This guidance helps manufacturers, importers, and distributors meet labelling obligations to protect public health and support safe device use. Full details, including examples, symbol explanations, and regulatory references, are available in the official Health Canada labelling guidance document and its appendices. Guidance on Labelling of Medical Devices Including In Vitro Diagnostic Devices - Appendices - Canada.ca
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Preparing an Application for Investigational Testing of In Vitro Diagnostic Devices – Health Canada Guidance
Health Canada’s guidance outlines the requirements and process for submitting an application for investigational testing authorization of in vitro diagnostic (IVD) devices in Canada, including when an ITA is needed, required documentation, risk-based considerations, ethics review coordination, and post-authorization obligations to ensure participant safety and data integrity during clinical performance studies.
Approximately 5 minutes
Guidance on Private Label Medical Devices – Health Canada Overview
Health Canada’s guidance clarifies regulatory obligations for private label (rebranded) medical devices, requiring the private label company to hold its own medical device establishment licence and, in most cases, its own device licence unless the original manufacturer’s licence covers the specific labelling and intended use, ensuring equivalent safety and performance standards under the Medical Devices Regulations.
Approximately 5 minutes
Supporting Evidence for New or Amended Licence Applications – Class II, III, IV Medical Devices and IVDs – Health Canada Guidance
Health Canada’s guidance specifies the type and level of supporting evidence required for new or amended medical device licence applications for Class II, III, and IV devices including IVDs, emphasizing risk-based requirements for safety, effectiveness, quality, and clinical data proportionate to device risk and the nature of the amendment.
Approximately 5 minutes
Guidance for Manufacturers of HIV Diagnostic Kits – Health Canada Overview
Health Canada’s guidance outlines specific regulatory expectations and evidence requirements for manufacturers seeking licence approval for in vitro diagnostic kits intended to detect or confirm Human Immunodeficiency Virus (HIV) infection, covering performance standards, clinical evaluation, labelling, and post-market obligations to ensure reliable diagnostic accuracy and public health protection.